주요메뉴 바로가기 본문 바로가기

주메뉴

IBS Conferences

A novel therapeutic target for recovery after stroke

Inhibitory neurotransmitters in diseased brain cells impede recovery after stroke in mice

video_Diaschisis after stroke through astrocytic GABA
Click to watch the video

Researchers at the Center for Cognition and Sociality, within the Institute for Basic Science (IBS), Gwangju Institute of Science and Technology (GIST), and Korea Institute of Science and Technology (KIST) have discovered a new mechanism to explain the effects of subcortical strokes and a new possible therapeutic approach.

Every year, 15 million people worldwide suffer from stroke according to the World Health Organization. Five million of those die and another five million are permanently disabled. Stroke is one of the most commonly reported causes of death and greatly impacts patients’ quality of life. However, despite its prevalence and negative impact, there are no direct medical treatments for recovery after stroke and patients rely on rehabilitation.

A stroke occurs when the blood supply is interrupted or reduced due to bleeding or occlusion of blood vessels in some part of the brain. Brain cells subsequently begin to die within minutes, causing a regional brain damage. In addition, the stroke leads to a loss of function, called diaschisis, in other brain regions connected to the damaged area. Proposed 115 years ago, diaschisis worsens symptoms and prognosis of stroke patients. However, despite the broad clinical interest, diaschisis’ molecular and cellular mechanisms are still unknown.

In this study, the researchers reported that diaschisis in the cortex of the mouse brain with subcortical stroke is caused by the decline of neuronal activity, due to the reduction in neuronal glucose uptake. They showed that this is dependent on pathological changes of astrocytes, the most abundant cell type in the brain. “Astrocytes respond to the presence of any chemical disregulation, caused by stroke. They become reactive, proliferate and increase in size,” says C. Justin Lee, Director of the Cognitive Glioscience Group, at the IBS Center for Cognition and Sociality and co-corresponding author of this research. The researchers discovered that reactive astrocytes synthesize and release an excessive amount of GABA, an inhibitory neurotransmitter, that affects the activity of neighboring motor neurons.

Figure 1. Schematic diagram of subcortical stroke effects on the mouse brain and suggested therapeutic approach.
Figure 1. Schematic diagram of subcortical stroke effects on the mouse brain and suggested therapeutic approach. Stroke affects not only the brain areas where the blood supply is interrupted or reduced (infarct), but also other distal areas (diaschisis). The researchers studied mouse brains and found that diaschisis is due to the excessive production of the neurotransmitter GABA and that the administration of KDS2010 combined with rehabilitation can improve motor function after stroke.

They also demonstrated that the diaschisis is significantly alleviated by the treatment with KDS2010, which efficiently blocks astrocytic GABA synthesis. developed by the same group, KDS2010 is currently licensed out to the pharmaceutical company, Neurobiogen. It works by inhibiting MAO-B, one of the key enzymes in the production of GABA. They further reported that rehabilitation training of the animals with stroke was not effective to recover the motor function. However, the treatment with KDS2010 accompanied by rehabilitation training dramatically mitigated the motor impairment due the stroke.

“Our findings demonstrate that astrocytic GABA-mediated cortical diaschisis impedes functional recovery after white matter stroke,” explains NAM Min-Ho, researcher at KIST and first author of the study.

“Diaschisis is observed in migraine, glioblastoma, traumatic brain injury in addition to stroke. This study will provide a novel therapeutic approach for those diseases as well,” adds KIM Hyoung-Ihl, researcher at GIST and co-corresponding author of the study.

In conclusion, the researchers suggest that blocking astrocytic GABA synthesis with KDS2010 alleviates cortical diaschisis, and stimulates rehabilitation-aided functional recovery in white matter stroke.

Notes for editors

- References
Min-Ho Nam, Jongwook Cho, Dae-Hyuk Kwon, Ji-Young Park, Junsung Woo, Jungmoo Lee, Sangwon Lee, Hae Young Ko, Woojin Won, Ra Gyung Kim, Hanlim Song, Soo-Jin Oh, Ji Won Choi, Ki Duk Park, Haejin Jung, Hyung-Seok Kim, Min-Cheol Lee, Mijin Yun, C. Justin Lee, Hyoung-Ihl Kim. Excessive astrocytic GABA causes cortical hypometabolism and impedes functional recovery following subcortical stroke. Cell Reports (2020).

- Media Contact
C. Justin Lee, Center for Cognition and Sociality, Institute for Basic Science (IBS) (+82-42-878-9150; cjl@ibs.re.kr); Mr. Daewoong Bae, Head of IBS Communications Team (+82-42-878-8195, woongs@ibs.re.kr); or Ms. Dahee Carol Kim, Public Information Officer of IBS & Science Communicator (+82-42-878-8133, clitie620@ibs.re.kr)

- About the Institute for Basic Science (IBS)
IBS was founded in 2011 by the government of the Republic of Korea with the sole purpose of driving forward the development of basic science in South Korea. IBS has 30 research centers as of January 2020. There are ten physics, two mathematics, six chemistry, six life science, one Earth science, and five interdisciplinary research centers.

  • [sciencedaily] A novel therapeutic target for recovery after stroke
  • [GEN] A novel therapeutic target for recovery after stroke
  • [todayheadline] A novel therapeutic target for recovery after stroke
  • [eurekalert] A novel therapeutic target for recovery after stroke
  • [sciencecodex] A novel therapeutic target for recovery after stroke
  • [medicalxpress] A novel therapeutic target for recovery after stroke
  • Research

    Are you satisfied with the information on this page?

    Content Manager
    Communications Team : Choi Jee Won   042-878-8088
    Last Update 2019-12-17 14:52